https://m2.mtmt.hu/ hun 2026-09-21 18:31 JournalArticle 34826851 VALIDATED true Összes idézések száma a WoS-ban: 0 0 false 2026-09-21T08:51:37.707+0000 2026-04-01T18:01:58.548+0000 2024-04-29T19:03:55.166+0000 true 10015206 Áncsán Gizella /api/admin/10015206 Admin Áncsán Gizella (SE admin) true 10015206 2026-04-09T12:44:44.689+0000 2025-04-18T13:45:55.296+0000 true 10065569 Pécsi Éva /api/admin/10065569 Admin Pécsi Éva (MTMT Közp 2,3, admin) true true false true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle true 1134514 Survey paper true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle /api/subtype/1134514 Összefoglaló cikk SubType Összefoglaló cikk (Folyóiratcikk) 102 true 1134514 true 1 /api/category/1 Category Tudományos true 1 Gadó, Klara true true /api/journal/10066103 REVIEWED PHYSIOLOGY INTERNATIONAL 2498-602X 2677-0164 true true 10066103 false 10066103 true 2498-602X 2677-0164 Journal FOREIGN 111 2 143 164 143 22 2024 Type 2 diabetes is a frequent chronic disease. Given its strong positive association with older age, it is a significant public health issue in elderly populations. Furthermore, the aging of the population, driven by increasing life expectancy in high and middle-income countries leads to an increasing prevalence of diabetes. true true 2024 false true true false true false GOLD 2026-09-21 true https://doi.org/10.1556/2060.2024.00317 20 0 20 20 0 20 20 13 16 17 17 17 17 20 0 0 20 20 20 20 0 18 18 Folyóiratcikk Journal Article 24 19 Könyvrészlet Chapter in Book 25 1 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2025 0 13 13 13 13 2026 0 7 7 7 7 Q2 false 10023535,10020334 false false false 2024-06-30T12:05:20.656+0000 Belgyógyászati és Onkológiai Klinika (SE / AOK / K); Egészségtudományi Klinikai Tanszék (SE / ETK2007); Geriátriai Klinika és Ápolástudományi Központ (SE / KKP); Morfológiai és Fiziológiai Tanszék (SE / ETK2007); Népegészségtani Intézet (SE / AOK / I); Physiology International szerkesztősége (Kiadók / MTA KFB); Társadalomtudományi Tanszék (SE / ETK2007) 5 38 7 5 0 true Language 10002 /api/language/10002 Angol Angol English true 2 true PersonAuthorship 116434260 /api/authorship/116434260 Gadó, Klara ✉ [Gadó, Klára (Belgyógyászat), szerző] Egészségtudományi Klinikai Tanszék (SE / ETK2007); Geriátriai Klinika és Ápolástudományi Központ (SE / KKP) 1 0.2 true false true Author 10023522 /api/author/10023522 Gadó Klára (Belgyógyászat) Gadó Klára true 10023522 true Gadó Klara true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116434261 /api/authorship/116434261 Tabák, Gy. Ádám [Tabák, Ádám (belgyógyászat, di...), szerző] Népegészségtani Intézet (SE / AOK / I); Belgyógyászati és Onkológiai Klinika (SE / AOK / K) 2 0.2 false false false Author 10024030 /api/author/10024030 Tabák Ádám (belgyógyászat, diabetológia) Tabák Ádám true 10024030 true Tabák Gy. Ádám true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116434262 /api/authorship/116434262 Vingender, István [Vingender, István (Egészségtudomány,...), szerző] Társadalomtudományi Tanszék (SE / ETK2007) 3 0.2 false false false Author 10023535 /api/author/10023535 Vingender István (Egészségtudomány, társadalomtudomány) Vingender István true 10023535 true Vingender István true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116434263 /api/authorship/116434263 Domján, Gyula [Domján, Gyula (Belgyógyászat), szerző] Egészségtudományi Klinikai Tanszék (SE / ETK2007) 4 0.2 false false false Author 10020334 /api/author/10020334 Domján Gyula (Belgyógyászat) Domján Gyula true 10020334 true Domján Gyula true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116434264 /api/authorship/116434264 Dörnyei, Gabriella [Bednárikné Dörnyei, Gabriella (Érfiziológia), szerző] Morfológiai és Fiziológiai Tanszék (SE / ETK2007) 5 0.2 false true false Author 10010428 /api/author/10010428 Bednárikné Dörnyei Gabriella (Érfiziológia) Bednárikné Dörnyei Gabriella true 10010428 true Dörnyei Gabriella true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true Institute 22712 /api/institute/22712 Physiology International szerkesztősége Kiadók / MTA KFB 0 false false true Physiology International szerkesztősége Editorial Office of the Physiology International true true PublicationIdentifier 26104317 /api/publicationidentifier/26104317 DOI: 10.1556/2060.2024.00317 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true GOLD true IDENTICAL 10.1556/2060.2024.00317 https://doi.org/10.1556/2060.2024.00317 false true PublicationIdentifier 26700906 /api/publicationidentifier/26700906 REAL: 198078 SwordSource 36 /api/publicationsource/36 REAL PublicationSourceType 10007 /api/publicationsourcetype/10007 Repozitórium true true true REAL REAL https://real.mtak.hu/@@@ true true 36 true GREEN true 198078 https://real.mtak.hu/198078 false true PublicationIdentifier 26829072 /api/publicationidentifier/26829072 WoS: 001258892300001 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 001258892300001 https://www.webofscience.com/wos/woscc/full-record/001258892300001 true true PublicationIdentifier 26747842 /api/publicationidentifier/26747842 Scopus: 85196766435 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 85196766435 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85196766435 true true PublicationIdentifier 26747844 /api/publicationidentifier/26747844 PubMed: 38683666 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 38683666 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=38683666&dopt=Abstract true true Classification 12215 /api/classification/12215 Klinikai orvostan true true SjrRating 11449892 /api/sjrrating/11449892 sjr:Q2 (2024) Scopus - Complementary and Alternative Medicine PHYSIOLOGY INTERNATIONAL 2498-602X 2677-0164 49 0.49 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 2707 /api/classificationexternal/2707 Scopus - Complementary and Alternative Medicine true 2707 true Q2 DIRECT true true Reference 52398498 /api/reference/52398498 1. U.S. Department of Health and Human Services. National diabetes statistics report 2020: estimates of diabetes and its burden in the United States. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services; 2020. Available from: https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf. 1 false true Reference 52398499 /api/reference/52398499 2. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87(1): 4–14. https://doi.org/10.1016/j.diabres.2009.10.007. 2 false true Reference 52398500 /api/reference/52398500 3. Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of type 2 diabetes – global burden of disease and forecasted trends. J Epidemiol Glob Health 2020; 10(1): 107–11. https://doi.org/10.2991/jegh.k.191028.001. 3 false true Reference 52398501 /api/reference/52398501 4. United Nations, Department of Economic and Social Affairs. World population prospects 2019: highlights (ST/ESA/SER.A/423). New York, NY: United Nations; 2019. Available from: https://population.un.org/wpp/publications/files/wpp2019_highlights.pdf. 4 false true Reference 52398502 /api/reference/52398502 5. Boyle JP, Honeycutt AA, Narayan KM, Hoerger TJ, Geiss LS, Chen H, et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care 2001; 24(11): 1936–40. https://doi.org/10.2337/diacare.24.11.1936. 5 false true Reference 52398503 /api/reference/52398503 6. Kumar V, Abbas AK, Aster JC, editors. Robbins and Cotran pathologic basis of disease, Ninth ed.. Philadelphia, PA: Elsevier; 2015. 6 false true Reference 52398504 /api/reference/52398504 7. Strayer DS, Rubin E, Saffitz JE, Schiller AL, editors. Rubin's pathology: clinicopathologic foundations of medicine, Eighth ed.. Philadelphia, PA: Wolters Kluwer Health; 2019. 7 false true Reference 52398505 /api/reference/52398505 8. Gregg EW, Engelgau MM, Narayan V. Complications of diabetes in elderly people. BMJ 2002; 325(7370): 916–7. https://doi.org/10.1136/bmj.325.7370.916. 8 false true Reference 52398506 /api/reference/52398506 9. Barbiellini Amidei C, Fayosse A, Dumurgier J, Machado-Fragua MD, Tabak AG, van Sloten T, et al. Association between age at diabetes onset and subsequent risk of dementia. JAMA 2021; 325(16): 1640–9. https://doi.org/10.1001/jama.2021.4001. 9 false true Reference 52398507 /api/reference/52398507 10. Bellia C, Lombardo M, Meloni M, Della-Morte D, Bellia A, Lauro D. Diabetes and cognitive decline. Adv Clin Chem 2022; 108: 37–71. https://doi.org/10.1016/bs.acc.2021.07.006., DOI: 10.1016/bs.acc.2021.07.006 10 10.1016/bs.acc.2021.07.006 false true Reference 52398508 /api/reference/52398508 11. Gregg EW. The changing tides of the type 2 diabetes epidemic-smooth sailing or troubled waters ahead? Kelly west award lecture 2016. Diabetes Care 2017; 40(10): 1289–97. https://doi.org/10.2337/dci16-0055. 11 false true Reference 52398509 /api/reference/52398509 12. Kalra S, Gupta Y. Prevention of hypoglycaemia, the ASAP (anticipate, suspect, act, prevent) strategy. J Pak Med Assoc 2017; 67(4): 648–9. 12 false true Reference 52398510 /api/reference/52398510 13. GBD 2019 Viewpoint Collaborators. Five insights from the global burden of disease study 2019. Lancet 2020; 396(10258): 1135–59. https://doi.org/10.1016/s0140-6736(20)31404-5. 13 false true Reference 52398511 /api/reference/52398511 14. World Health Organization. Global report on diabetes. Geneva: World Health Organization; 2016. 14 false true Reference 52398512 /api/reference/52398512 15. Saeedi P, Salpea P, Karuranga S, Petersohn I, Malanda B, Gregg EW, et al. Mortality attributable to diabetes in 20-79 years old adults, 2019 estimates: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract 2020; 162: 108086. https://doi.org/10.1016/j.diabres.2020.108086. 15 false true Reference 52398513 /api/reference/52398513 16. Domján BA, Ferencz V, Tänczer T, Szili-Janicsek Z, Barkai L, Hidvégi T, et al. Large increase in the prevalence of self-reported diabetes based on a nationally representative survey in Hungary. Prim Care Diabetes 2017; 11(2): 107–11. https://doi.org/10.1016/j.pcd.2016.09.001. 16 false true Reference 52398514 /api/reference/52398514 17. Koenen M, Hill MA, Cohen P, Sowers JR. Obesity, adipose tissue and vascular dysfunction. Circ Res 2021; 128(7): 951–68. https://doi.org/10.1161/circresaha.121.318093. 17 false true Reference 52398515 /api/reference/52398515 18. Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, et al. Diabetes in older adults. Diabetes Care 2012; 35(12): 2650–64. https://doi.org/10.2337/dc12-1801. 18 false true Reference 52398516 /api/reference/52398516 19. Bradley D, Hsueh W. Type 2 diabetes in the elderly: challenges in a unique patient population. J Geriatr Med Gerontol 2016; 2(2). https://doi.org/10.23937/2469-5858/1510014. 19 false true Reference 52398517 /api/reference/52398517 20. International Diabetes Federation. IDF diabetes atlas, Seventh ed. Brussels: International Diabetes Federation; 2015. Available from: https://www.diabetesatlas.org/upload/resources/previous/files/7/IDF%20Diabetes%20Atlas%207th.pdf. 20 false true Reference 52398518 /api/reference/52398518 21. Christensen DL, Witte DR, Kaduka L, Jørgensen ME, Borch-Johnsen K, Mohan V, et al. Moving to an A1C-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups. Diabetes Care 2010; 33(3): 580–2. https://doi.org/10.2337/dc09-1843. 21 false true Reference 52398519 /api/reference/52398519 22. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services; 2011. Available from: https://www.diabetesincontrol.com/wp-content/uploads/PDF/ndep_diabetes_facts_2011.pdf. 22 false true Reference 52398520 /api/reference/52398520 23. Tabák AG, Brunner EJ, Lindbohm JV, Singh-Manoux A, Shipley MJ, Sattar N, et al. Risk of macrovascular and microvascular disease in diabetes diagnosed using oral glucose tolerance test with and without confirmation by hemoglobin A1c: the Whitehall II cohort study. Circulation 2022; 146(13): 995–1005. https://doi.org/10.1161/circulationaha.122.059430. 23 false true Reference 52398521 /api/reference/52398521 24. Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for diabetes development. Lancet 2012; 379(9833): 2279–90. https://doi.org/10.1016/s0140-6736(12)60283-9. 24 false true Reference 52398522 /api/reference/52398522 25. Kalra S, Sharma SK. Diabetes in the elderly. Diabetes Ther 2018; 9(2): 493–500. https://doi.org/10.1007/s13300-018-0380-x. 25 false true Reference 52398523 /api/reference/52398523 26. Tabák AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimäki M, Witte DR. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 2009; 373(9682): 2215–21. https://doi.org/10.1016/s0140-6736(09)60619-x. 26 false true Reference 52398524 /api/reference/52398524 27. Chentli F, Azzoug S, Mahgoun S. Diabetes mellitus in elderly. Indian J Endocrinol Metab 2015; 19(6): 744–52. https://doi.org/10.4103/2230-8210.167553. 27 false true Reference 52398525 /api/reference/52398525 28. Meneilly GS, Veldhuis JD, Elahi D. Deconvolution analysis of rapid insulin pulses before and after six weeks of continuous subcutaneous administration of glucagon-like peptide-1 in elderly patients with type 2 diabetes. J Clin Endocrin Metab 2005; 90(11): 6251–6. https://doi.org/10.1210/jc.2004-2100. 28 false true Reference 52398526 /api/reference/52398526 29. Muller DC, Elahi D, Tobin JD, Andres R. The effect of age on insulin resistance and secretion: a review. Semin Nephrol 1996; 16(4): 289–98. 29 false true Reference 52398527 /api/reference/52398527 30. Jayedi A, Soltani S, Abdolshahi A, Shab-Bidar S. Healthy and unhealthy dietary patterns and the risk of chronic disease: an umbrella review of meta-analyses of prospective cohort studies. Br J Nutr 2020; 124(11): 1133–44. https://doi.org/10.1017/s0007114520002330. 30 false true Reference 52398528 /api/reference/52398528 31. Song MK, Rosenthal MJ, Naliboff BD, Phanumas L, Kang KW. Effects of bovine prostate powder on zinc, glucose, and insulin metabolism in old patients with non-insulin-dependent diabetes mellitus. Metabolism 1998; 47(1): 39–43. https://doi.org/10.1016/s0026-0495(98)90190-1. 31 false true Reference 52398529 /api/reference/52398529 32. Salminen A. Clinical perspectives on the age-related increase of immunosuppressive activity. J Mol Med (Berl) 2022; 100(5): 697–712. https://doi.org/10.1007/s00109-022-02193-4. 32 false true Reference 52398530 /api/reference/52398530 33. Samson LD, Buisman AM, Ferreira JA, Picavet HSJ, Verschuren WMM, Boots AM, et al. Inflammatory marker trajectories associated with frailty and ageing in a 20-year longitudinal study. Clin Transl Immunol 2022; 11(2): e1374. https://doi.org/10.1002/cti2.1374. 33 false true Reference 52398531 /api/reference/52398531 34. Carstensen M, Herder C, Kivimäki M, Jokela M, Roden M, Shipley MJ, et al. Accelerated increase in serum interleukin-1 receptor antagonist starts 6 years before diagnosis of type 2 diabetes: Whitehall II prospective cohort study. Diabetes 2010; 59(5): 1222–7. https://doi.org/10.2337/db09-1199. 34 false true Reference 52398532 /api/reference/52398532 35. Herder C, Zierer A, Koenig W, Roden M, Meisinger C, Thorand B. Transforming growth factor-beta1 and incident type 2 diabetes: results from the MONICA/KORA case-cohort study, 1984-2002. Diabetes Care 2009; 32(10): 1921–3. https://doi.org/10.2337/dc09-0476. 35 false true Reference 52398533 /api/reference/52398533 36. Tabák AG, Brunner EJ, Miller MA, Karanam S, McTernan PG, Cappuccio FP, et al. Low serum adiponectin predicts 10-year risk of type 2 diabetes and HbA1c independently of obesity, lipids, and inflammation: Whitehall II study. Horm Metab Res 2009; 41(8): 626–9. https://doi.org/10.1055/s-0029-1216359. 36 false true Reference 52398534 /api/reference/52398534 37. Tabák AG, Carstensen M, Witte DR, Brunner EJ, Shipley MJ, Jokela M, et al. Adiponectin trajectories before type 2 diabetes diagnosis: Whitehall II study. Diabetes Care 2012; 35(12): 2540–7. https://doi.org/10.2337/dc11-2263. 37 false true Reference 52398535 /api/reference/52398535 38. Grossmann M, Gianatti EJ, Zajac JD. Testosterone and type 2 diabetes. Curr Opin Endocrinol Diabetes Obes 2010; 17(3): 247–56. https://doi.org/10.1097/MED.0b013e32833919cf. 38 false true Reference 52398536 /api/reference/52398536 39. Rothenbacher D, Dallmeier D, Denkinger MD, Boehm BO, Koenig W, Klenk J. Physical activity and sex hormone-binding globulin in older adults. J Aging Phys Act 2019; 27(5): 621–4. https://doi.org/10.1123/japa.2018-0171. 39 false true Reference 52398537 /api/reference/52398537 40. Best JD, Kahn SE, Ader M, Watanabe RM, Ni TC, Bergman RN. Role of glucose effectiveness in the determination of glucose tolerance. Diabetes Care 1996; 19(9): 1018–30. https://doi.org/10.2337/diacare.19.9.1018. 40 false true Reference 52398538 /api/reference/52398538 41. Leslie RD, Williams R, Pozzilli P. Clinical review: type 1 diabetes and latent autoimmune diabetes in adults: one end of the rainbow. J Clin Endocrinol Metab 2006; 91(5): 1654–9. https://doi.org/10.1210/jc.2005-1623. 41 false true Reference 52398539 /api/reference/52398539 42. Dominguez LJ, Paolisso G, Barbagallo M. Glucose control in the older patient: from intensive, to effective and safe. Aging Clin Exp Res 2010; 22(4): 274–80. https://doi.org/10.1007/bf03337724. 42 false true Reference 52398540 /api/reference/52398540 43. Babiker A, Al Dubayee M. Anti-diabetic medications: how to make a choice? Sudan J Paediatr 2017; 17(2): 11–20. https://doi.org/10.24911/sjp.2017.2.12. 43 false true Reference 52398541 /api/reference/52398541 44. Kivimäki M, Tabák AG. Does addressing prediabetes help to improve population health? Lancet Diabetes Endocrinol 2018; 6(5): 354–6. https://doi.org/10.1016/s2213-8587(18)30030-5. 44 false true Reference 52398542 /api/reference/52398542 45. Beulens J, Rutters F, Rydén L, Schnell O, Mellbin L, Hart HE, et al. Risk and management of pre-diabetes. Eur J Prev Cardiol 2019; 26(2_suppl): 47–54. https://doi.org/10.1177/2047487319880041. 45 false true Reference 52398543 /api/reference/52398543 46. American Diabetes Association Professional Practice Committee. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care 2022; 45(Suppl 1): S17–s38. https://doi.org/10.2337/dc22-S002. 46 false true Reference 52398544 /api/reference/52398544 47. American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021. Diabetes Care 2021; 44(Suppl 1): S15–s33. https://doi.org/10.2337/dc21-S002. 47 false true Reference 52398545 /api/reference/52398545 48. Bajwa SJ, Sehgal V, Kalra S, Baruah MP. Management of diabetes mellitus type-2 in the geriatric population: current perspectives. J Pharm Bioallied Sci 2014; 6(3): 151–7. https://doi.org/10.4103/0975-7406.130956. 48 false true Reference 52398546 /api/reference/52398546 49. Khan RMM, Chua ZJY, Tan JC, Yang Y, Liao Z, Zhao Y. From pre-diabetes to diabetes: diagnosis, treatments and translational research. Medicina (Kaunas) 2019; 55(9): 546. https://doi.org/10.3390/medicina55090546. 49 false true Reference 52398547 /api/reference/52398547 50. Lindbohm JV, Sipilä PN, Mars N, Knüppel A, Pentti J, Nyberg ST, et al. Association between change in cardiovascular risk scores and future cardiovascular disease: analyses of data from the Whitehall II longitudinal, prospective cohort study. Lancet Digit Health 2021; 3(7): e434–e44. https://doi.org/10.1016/s2589-7500(21)00079-0. 50 false true Reference 52398548 /api/reference/52398548 51. Danna SM, Graham E, Burns RJ, Deschênes SS, Schmitz N. Association between depressive symptoms and cognitive function in persons with diabetes mellitus: a systematic review. PLoS One 2016; 11(8): e0160809. https://doi.org/10.1371/journal.pone.0160809. 51 false true Reference 52398549 /api/reference/52398549 52. Damaskos C, Garmpis N, Kollia P, Mitsiopoulos G, Barlampa D, Drosos A, et al. Assessing cardiovascular risk in patients with diabetes: an update. Curr Cardiol Rev 2020; 16(4): 266–74. https://doi.org/10.2174/1573403x15666191111123622. 52 false true Reference 52398550 /api/reference/52398550 53. Fayosse A, Nguyen DP, Dugravot A, Dumurgier J, Tabak AG, Kivimäki M, et al. Risk prediction models for dementia: role of age and cardiometabolic risk factors. BMC Med 2020; 18(1): 107. https://doi.org/10.1186/s12916-020-01578-x. 53 false true Reference 52398551 /api/reference/52398551 54. Moreira Bde S, Sampaio RF, Furtado SR, Dias RC, Kirkwood RN. The relationship between diabetes mellitus, geriatric syndromes, physical function, and gait: a review of the literature. Curr Diabetes Rev 2016; 12(3): 240–51. https://doi.org/10.2174/1573399811666150615142746. 54 false true Reference 52398552 /api/reference/52398552 55. Moreno G, Mangione CM, Kimbro L, Vaisberg E. Guidelines abstracted from the American geriatrics society guidelines for improving the care of older adults with diabetes mellitus: 2013 update. J Am Geriatr Soc 2013; 61(11): 2020–6. https://doi.org/10.1111/jgs.12514. 55 false true Reference 52398553 /api/reference/52398553 56. Tabák AG, Akbaraly TN, Batty GD, Kivimäki M. Depression and type 2 diabetes: a causal association? Lancet Diabetes Endocrinol 2014; 2(3): 236–45. https://doi.org/10.1016/s2213-8587(13)70139-6. 56 false true Reference 52398554 /api/reference/52398554 57. Kivimäki M, Tabák AG, Lawlor DA, Batty GD, Singh-Manoux A, Jokela M, et al. Antidepressant use before and after the diagnosis of type 2 diabetes: a longitudinal modeling study. Diabetes Care 2010; 33(7): 1471–6. https://doi.org/10.2337/dc09-2359. 57 false true Reference 52398555 /api/reference/52398555 58. Evans DL, Charney DS, Lewis L, Golden RN, Gorman JM, Krishnan KR, et al. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 2005; 58(3): 175–89. https://doi.org/10.1016/j.biopsych.2005.05.001. 58 false true Reference 52398556 /api/reference/52398556 59. Park M, Reynolds CF. 3rd. Depression among older adults with diabetes mellitus. Clin Geriatr Med 2015; 31(1): 117–37, ix. https://doi.org/10.1016/j.cger.2014.08.022. 59 false true Reference 52398557 /api/reference/52398557 60. Ludman EJ, Katon W, Russo J, Von Korff M, Simon G, Ciechanowski P, et al. Depression and diabetes symptom burden. Gen Hosp Psychiatry 2004; 26(6): 430–6. https://doi.org/10.1016/j.genhosppsych.2004.08.010. 60 false true Reference 52398558 /api/reference/52398558 61. Huang ES, Laiteerapong N, Liu JY, John PM, Moffet HH, Karter AJ. Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study. JAMA Intern Med 2014; 174(2): 251–8. https://doi.org/10.1001/jamainternmed.2013.12956. 61 false true Reference 52398559 /api/reference/52398559 62. International Hypoglycaemia Study Group. Glucose concentrations of less than 3.0 mmol/L (54 mg/dL) should be reported in clinical trials: a joint position statement of the American diabetes association and the European association for the study of diabetes. Diabetes Care 2017; 40(1): 155–7. https://doi.org/10.2337/dc16-2215. 62 false true Reference 52398560 /api/reference/52398560 63. Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, et al. Hypoglycemia and diabetes: a report of a workgroup of the American diabetes association and the endocrine society. Diabetes Care 2013; 36(5): 1384–95. https://doi.org/10.2337/dc12-2480. 63 false true Reference 52398561 /api/reference/52398561 64. Agiostratidou G, Anhalt H, Ball D, Blonde L, Gourgari E, Harriman KN, et al. Standardizing clinically meaningful outcome measures beyond HbA(1c) for type 1 diabetes: a consensus report of the American association of clinical endocrinologists, the American association of diabetes educators, the American diabetes association, the endocrine society, JDRF international, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange. Diabetes Care 2017; 40(12): 1622–30. https://doi.org/10.2337/dc17-1624. 64 false true Reference 52398562 /api/reference/52398562 65. Freeman J. Management of hypoglycemia in older adults with type 2 diabetes. Postgrad Med 2019; 131(4): 241–50. https://doi.org/10.1080/00325481.2019.1578590. 65 false true Reference 52398563 /api/reference/52398563 66. Hope SV, Taylor PJ, Shields BM, Hattersley AT, Hamilton W. Are we missing hypoglycaemia? Elderly patients with insulin-treated diabetes present to primary care frequently with non-specific symptoms associated with hypoglycaemia. Prim Care Diabetes 2018; 12(2): 139–46. https://doi.org/10.1016/j.pcd.2017.08.004. 66 false true Reference 52398564 /api/reference/52398564 67. Piro S, Purrello F. Acute diabetes complications. J Gerontol Geriatr 2021; 69(4): 269–75. https://doi.org/10.36150/2499-6564-N457. 67 false true Reference 52398565 /api/reference/52398565 68. Fadini GP, de Kreutzenberg SV, Rigato M, Brocco S, Marchesan M, Tiengo A, et al. Characteristics and outcomes of the hyperglycemic hyperosmolar non-ketotic syndrome in a cohort of 51 consecutive cases at a single center. Diabetes Res Clin Pract 2011; 94(2): 172–9. https://doi.org/10.1016/j.diabres.2011.06.018. 68 false true Reference 52398566 /api/reference/52398566 69. Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care 2009; 32(7): 1335–43. https://doi.org/10.2337/dc09-9032. 69 false true Reference 52398567 /api/reference/52398567 70. Atif M, Saleem Q, Babar ZU, Scahill S. Association between the vicious cycle of diabetes-associated complications and glycemic control among the elderly: a systematic review. Medicina (Kaunas) 2018; 54(5): 73. https://doi.org/10.3390/medicina54050073. 70 false true Reference 52398568 /api/reference/52398568 71. Kitabchi AE, Nyenwe EA. Hyperglycemic crises in diabetes mellitus: diabetic ketoacidosis and hyperglycemic hyperosmolar state. Endocrinol Metab Clin North Am 2006; 35(4): 725–51. viii https://doi.org/10.1016/j.ecl.2006.09.006. 71 false true Reference 52398569 /api/reference/52398569 72. Kitabchi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI, et al. Management of hyperglycemic crises in patients with diabetes. Diabetes Care 2001; 24(1): 131–53. https://doi.org/10.2337/diacare.24.1.131. 72 false true Reference 52398570 /api/reference/52398570 73. Karslioglu French E, Donihi AC, Korytkowski MT. Diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome: review of acute decompensated diabetes in adult patients. BMJ 2019; 365: l1114. https://doi.org/10.1136/bmj.l1114. 73 false true Reference 52398571 /api/reference/52398571 74. Shahid W, Khan F, Makda A, Kumar V, Memon S, Rizwan A. Diabetic ketoacidosis: clinical characteristics and precipitating factors. Cureus 2020; 12(10): e10792. https://doi.org/10.7759/cureus.10792. 74 false true Reference 52398572 /api/reference/52398572 75. Lewis III JL. Metabolic acidosis - endocrine and metabolic disorders. In: Merck manual professional edition [internet]. Rahway, NJ: Merck & Co.; 2023. Available from: https://www.merckmanuals.com/professional/endocrine-and-metabolic-disorders/acid-base-regulation-and-disorders/metabolic-acidosis. 75 false true Reference 52398573 /api/reference/52398573 76. Shaw J. Diabetes: regional variation in lower limb amputation incidence. Nat Rev Endocrinol 2012; 8(7): 386–8. https://doi.org/10.1038/nrendo.2012.78. 76 false true Reference 52398574 /api/reference/52398574 77. Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010; 33(10): 2285–93. https://doi.org/10.2337/dc10-1303. 77 false true Reference 52398575 /api/reference/52398575 78. Braunwald E.. Diabetes, heart failure, and renal dysfunction: the vicious circles. Prog Cardiovasc Dis 2019; 62(4): 298–302. https://doi.org/10.1016/j.pcad.2019.07.003. 78 false true Reference 52398576 /api/reference/52398576 79. Lotfy M, Adeghate J, Kalasz H, Singh J, Adeghate E. Chronic complications of diabetes mellitus: a mini review. Curr Diabetes Rev 2017; 13(1): 3–10. https://doi.org/10.2174/1573399812666151016101622. 79 false true Reference 52398577 /api/reference/52398577 80. Chung WK, Erion K, Florez JC, Hattersley AT, Hivert MF, Lee CG, et al. Precision medicine in diabetes: a consensus report from the American diabetes association (ADA) and the European association for the study of diabetes (EASD). Diabetes Care 2020; 43(7): 1617–35. https://doi.org/10.2337/dci20-0022. 80 false true Reference 52398578 /api/reference/52398578 81. Sesti G, Antonelli Incalzi R, Bonora E, Consoli A, Giaccari A, Maggi S, et al. Management of diabetes in older adults. Nutr Metab Cardiovasc Dis 2018; 28(3): 206–18. https://doi.org/10.1016/j.numecd.2017.11.007. 81 false true Reference 52398579 /api/reference/52398579 82. Natali A, Ferrannini E. Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review. Diabetologia 2006; 49(3): 434–41. https://doi.org/10.1007/s00125-006-0141-7. 82 false true Reference 52398580 /api/reference/52398580 83. Bell DSH. Metformin-induced vitamin B12 deficiency can cause or worsen distal symmetrical, autonomic and cardiac neuropathy in the patient with diabetes. Diabetes Obes Metab 2022; 24(8): 1423–8. https://doi.org/10.1111/dom.14734. 83 false true Reference 52398581 /api/reference/52398581 84. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012; 35(6): 1364–79. https://doi.org/10.2337/dc12-0413. 84 false true Reference 52398582 /api/reference/52398582 85. Hernández C, Bogdanov P, Corraliza L, García-Ramírez M, Solà-Adell C, Arranz JA, et al. Topical administration of GLP-1 receptor agonists prevents retinal neurodegeneration in experimental diabetes. Diabetes 2016; 65(1): 172–87. https://doi.org/10.2337/db15-0443. 85 false true Reference 52398583 /api/reference/52398583 86. Steven S, Jurk K, Kopp M, Kröller-Schön S, Mikhed Y, Schwierczek K, et al. Glucagon-like peptide-1 receptor signalling reduces microvascular thrombosis, nitro-oxidative stress and platelet activation in endotoxaemic mice. Br J Pharmacol 2017; 174(12): 1620–32. https://doi.org/10.1111/bph.13549. 86 false true Reference 52398584 /api/reference/52398584 87. Champlain JM. Practical considerations for use of insulin/glucagon-like peptide 1 receptor agonist combinations in older adults with type 2 diabetes. J Fam Pract 2022; 71(6 Suppl): S34–s9. https://doi.org/10.12788/jfp.0394. 87 false true Reference 52398585 /api/reference/52398585 88. Yin R, Xu Y, Wang X, Yang L, Zhao D. Role of dipeptidyl peptidase 4 inhibitors in antidiabetic treatment. Molecules 2022; 27(10): 3055. https://doi.org/10.3390/molecules27103055. 88 false true Reference 52398586 /api/reference/52398586 89. Bahne E, Sun EWL, Young RL, Hansen M, Sonne DP, Hansen JS, et al. Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes. JCI Insight 2018; 3(23): e93936. https://doi.org/10.1172/jci.insight.93936. 89 false true Reference 52398587 /api/reference/52398587 90. Piperidou A, Loutradis C, Sarafidis P. SGLT-2 inhibitors and nephroprotection: current evidence and future perspectives. J Hum Hypertens 2021; 35(1): 12–25. https://doi.org/10.1038/s41371-020-00393-4. 90 false true Reference 52398588 /api/reference/52398588 91. Solomon SD, McMurray JJV, Claggett B, de Boer RA, DeMets D, Hernandez AF, et al. Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med 2022; 387(12): 1089–98. https://doi.org/10.1056/NEJMoa2206286. 91 false true Reference 52398589 /api/reference/52398589 92. Souza ABF, Nascimento DAC, Rodrigues IJM, Charone CCO, Lopes GL, Lima RS, et al. Association between sarcopenia and diabetes in community dwelling elderly in the Amazon region – Viver Mais Project. Arch Gerontol Geriatr 2019; 83: 121–5. https://doi.org/10.1016/j.archger.2019.03.020. 92 false true Reference 52398590 /api/reference/52398590 93. Cleasby ME, Jamieson PM, Atherton PJ. Insulin resistance and sarcopenia: mechanistic links between common co-morbidities. J Endocrinol 2016; 229(2): R67–81. https://doi.org/10.1530/joe-15-0533. 93 false true Reference 52398591 /api/reference/52398591 94. Kong SH, Park YJ, Lee JY, Cho NH, Moon MK. Insulin resistance is associated with cognitive decline among older Koreans with normal baseline cognitive function: a prospective community-based cohort study. Sci Rep 2018; 8(1): 650. https://doi.org/10.1038/s41598-017-18998-0. 94 false true Reference 52398592 /api/reference/52398592 95. Tamura Y, Omura T, Toyoshima K, Araki A. Nutrition management in older adults with diabetes: a review on the importance of shifting prevention strategies from metabolic syndrome to frailty. Nutrients 2020; 12(11). https://doi.org/10.3390/nu12113367. 95 false true Reference 52398593 /api/reference/52398593 96. Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD). Eur Heart J 2020; 41(2): 255–323. https://doi.org/10.1093/eurheartj/ehz486. 96 false true Reference 52398594 /api/reference/52398594 97. Yuan S, Larsson SC. An atlas on risk factors for type 2 diabetes: a wide-angled Mendelian randomisation study. Diabetologia 2020; 63(11): 2359–71. https://doi.org/10.1007/s00125-020-05253-x. 97 false true Reference 52398595 /api/reference/52398595 98. Kolosi T, Róbert P. A magyar társadalom szerkezeti átalakulásának és mobilitásának fő folyamatai a rendszerváltás óta. In: Kolosi T, Tóth IG, Vukovich G, editors. Társadalmi riport 2004: TÁRKI; 2004. p. 48–74. 98 false true Reference 52398596 /api/reference/52398596 99. Clark ML, Utz SW. Social determinants of type 2 diabetes and health in the United States. World J Diabetes 2014; 5(3): 296–304. https://doi.org/10.4239/wjd.v5.i3.296. 99 false true Reference 52398597 /api/reference/52398597 100. Hill-Briggs F, Adler NE, Berkowitz SA, Chin MH, Gary-Webb TL, Navas-Acien A, et al. Social determinants of health and diabetes: a scientific review. Diabetes Care 2020; 44(1): 258–79. https://doi.org/10.2337/dci20-0053. 100 false true Reference 52398598 /api/reference/52398598 101. Bird Y, Lemstra M, Rogers M, Moraros J. The relationship between socioeconomic status/income and prevalence of diabetes and associated conditions: a cross-sectional population-based study in Saskatchewan, Canada. Int J Equity Health 2015; 14: 93. https://doi.org/10.1186/s12939-015-0237-0. 101 false true /api/publication/34826851 Gadó Klara et al. Treatment of type 2 diabetes mellitus in the elderly – Special considerations. (2024) PHYSIOLOGY INTERNATIONAL 2498-602X 2677-0164 111 2 143-164<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" mtid="10023522"><a href="/gui2/?type=authors&mode=browse&sel=10023522" target="_blank">Gadó Klara ✉ (<span class="authorship-author-name">Gadó Klára</span> <span class="authorAux-mtmt"> Belgyógyászat</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Egészségtudományi Kar">ETK2007</span>/Egészségtudományi Klinikai Tanszék; <span title="Semmelweis Egyetem">SE</span>/<span title="Klinikai Központ (karhoz nem tartozó egységek)">KKP</span>/Geriátriai Klinika és Ápolástudományi Központ</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10024030"><a href="/gui2/?type=authors&mode=browse&sel=10024030" target="_blank">Tabák Gy. Ádám (<span class="authorship-author-name">Tabák Ádám</span> <span class="authorAux-mtmt"> belgyógyászat, diabetológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Népegészségtani Intézet; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Belgyógyászati és Onkológiai Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10023535"><a href="/gui2/?type=authors&mode=browse&sel=10023535" target="_blank">Vingender István (<span class="authorship-author-name">Vingender István</span> <span class="authorAux-mtmt"> Egészségtudomány, társadalomtudomány</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Egészségtudományi Kar">ETK2007</span>/Társadalomtudományi Tanszék</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10020334"><a href="/gui2/?type=authors&mode=browse&sel=10020334" target="_blank">Domján Gyula (<span class="authorship-author-name">Domján Gyula</span> <span class="authorAux-mtmt"> Belgyógyászat</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Egészségtudományi Kar">ETK2007</span>/Egészségtudományi Klinikai Tanszék</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10010428"><a href="/gui2/?type=authors&mode=browse&sel=10010428" target="_blank">Dörnyei Gabriella (<span class="authorship-author-name">Bednárikné Dörnyei Gabriella</span> <span class="authorAux-mtmt"> Érfiziológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Egészségtudományi Kar">ETK2007</span>/Morfológiai és Fiziológiai Tanszék</span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;34826851" target="_blank">Treatment of type 2 diabetes mellitus in the elderly – Special considerations</a></div> <div> <span class="journal-title">PHYSIOLOGY INTERNATIONAL</span> <span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/2498-602X">2498-602X</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/2677-0164">2677-0164</a>)</span>: <span class="journal-volume">111</span> <span class="journal-issue">2</span> <span class="page"> pp 143-164 </span> <span class="year">(2024)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Angol | </span> <span class="identifiers"> <span class="id identifier oa_GOLD" title=" Gold "> <a style="color:blue" title="10.1556/2060.2024.00317" target="_blank" href="https://doi.org/10.1556/2060.2024.00317"> DOI </a> </span> <span class="id identifier oa_GREEN" title=" Green "> <a style="color:black" title="198078" target="_blank" href="https://real.mtak.hu/198078"> REAL </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="001258892300001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/001258892300001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85196766435" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85196766435"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="38683666" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=38683666&dopt=Abstract"> PubMed </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Folyóirat szakterülete: Scopus - Complementary and Alternative Medicine&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q2</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Medicine (miscellaneous)&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q3</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Orthopedics and Sports Medicine&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q3</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Physical Therapy, Sports Therapy and Rehabilitation&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q3</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Physiology (medical)&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q3</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="Nyilvános idézőközlemények összesen, említések nélkül" class="citingPub-count">Nyilvános idéző összesen: 20</span> | Független: 20 | Függő: 0 | Nem jelölt: 0 | WoS jelölt: 13 | Scopus jelölt:&nbsp;16 | WoS/Scopus jelölt:&nbsp;17 | DOI jelölt:&nbsp;20 </div> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;34826851&sort=publishedYear,desc&sort=title"> Idézett közlemények száma: 18 </a> </div> <div class="mtid"><span class="long-pub-mtid">Közlemény: 34826851</span> | <span class="status-data status-VALIDATED"> Egyeztetett </span> Forrás Idéző | <span class="type-subtype">Folyóiratcikk ( Összefoglaló cikk ) </span> | <span class="pub-category">Tudományos</span> | <span class="publication-sourceOfData">kézi felvitel</span> </div> <div class="special-affiliations"> Speciális affiliáció: Physiology International szerkesztősége </div> <div class="lastModified">Utolsó módosítás: 2026.04.01. 20:01 Molnár-Taga Márta (SE 4-es admin) </div> <pre class="comment" style="margin-top: 0; margin-bottom: 0;"><u>Megjegyzés</u>: Összes idézések száma a WoS-ban: 0</pre> </div></div>